Elanco Animal Health, Inc. (ELAN)
24.68
+0.76
(+3.20%)
USD |
NYSE |
Sep 02, 16:00
24.68
0.00 (0.00%)
After-Hours: 19:41
Elanco Animal Health Research and Development Expense (TTM) : 371.00M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 371.00M |
| March 31, 2026 | 371.00M |
| December 31, 2025 | 368.00M |
| September 30, 2025 | 356.00M |
| June 30, 2025 | 354.00M |
| March 31, 2025 | 351.00M |
| December 31, 2024 | 344.00M |
| September 30, 2024 | 342.00M |
| June 30, 2024 | 341.00M |
| March 31, 2024 | 333.00M |
| December 31, 2023 | 327.00M |
| September 30, 2023 | 328.00M |
| June 30, 2023 | 320.00M |
| March 31, 2023 | 321.00M |
| December 31, 2022 | 321.00M |
| September 30, 2022 | 333.00M |
| Date | Value |
|---|---|
| June 30, 2022 | 349.00M |
| March 31, 2022 | 361.00M |
| December 31, 2021 | 369.00M |
| September 30, 2021 | 389.70M |
| June 30, 2021 | 383.80M |
| March 31, 2021 | 349.20M |
| December 31, 2020 | 327.00M |
| September 30, 2020 | 281.60M |
| June 30, 2020 | 263.40M |
| March 31, 2020 | 272.80M |
| December 31, 2019 | 270.10M |
| September 30, 2019 | 263.90M |
| June 30, 2019 | 252.90M |
| March 31, 2019 | 245.50M |
| December 31, 2018 | 246.60M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Zoetis, Inc. | 722.00M |
| Eli Lilly & Co. | 14.60B |
| ANI Pharmaceuticals, Inc. | 49.91M |
| EyePoint, Inc. | 262.73M |
| Amylyx Pharmaceuticals, Inc. | 92.08M |